Next Investors logo grey

Roto-Gro International’s ag-tech blossoms in June quarter

|

Published 01-AUG-2018 13:22 P.M.

|

4 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

Ag-tech cannabis play, Roto-Gro International (ASX:RGI), has released its activities report for the June quarter, reporting strong progress across the full spectrum of its ag-tech operations.

Encouragingly, RGI is in a healthy cash position, having recently raised $4.56 million from sophisticated investors.

During the quarter, RGI completed its acquisition of Hanson Fertigation via its wholly owned subsidiary, Global Fertigation Solutions Inc (GFS). This pivotal acquisition provides a holistic solution to the agricultural industry at large, which encompasses traditional field farming, greenhouses, flat deck cultivation and rotational gardens.

This kind of leverage to the fertigation space, moreover, further expands RGI’s revenue streams and boosts its emergence as a global ag-tech solutions provider. Fertigation, which is paramount to modern hydroponics, is the injection of fertilizers, soil amendments, and other water-soluble products into an irrigation system.

It’s worth noting here that this is an early stage play and investors should seek professional financial advice if considering this company for their portfolio.

RGI also invested in organic perishable foods grower, Gibio Inc., which provides for it to subscribe for up to a 49 per cent equity stake. Part of this collaboration has seen RGI penning an exclusive 20-year exclusive, manufacturing, tech and service contract for all rotational garden systems required for Gibio’s perishable food facilities globally.

Gibio’s first flagship indoor vertical farming facility will comprise 420 8-foot diameter RotoGro Rotary Hydroponic Garden Systems — specifically designed by RGI to meet Gibio’s operational needs to harvest and supply 3,600 heads of cos lettuce per day for a prominent supermarket chain in Quebec.

The fast-moving RGI has also actioned its $2.3 million purchase order for Miracle Valley. The first $1 million has been received, triggering production of the RotoGro Hydroponic Garden Systems required by Miracle Valley to build out its 29,000 square foot state-of-the-art cultivation and manufacturing facility in British Columbia, Canada.

Due to delays with Miracle Valley’s construction contractors, it will be able to receive its first delivery of machines in August.

Meanwhile, RGI’s sales team continues its holistic approach — providing solutions from concept to harvest, integrating design and growing expertise — to enable engagement with prospective clients very early in the application and design phase. This ensures that the design of each facility maximises the advantages of the RotoGro System.

Further to that, Dr Hamid Hamiduzziman, a qualified botanist with a PhD in Molecular Plant Pathology from the University of Neuchatel, Switzerland, has joined RGI’s Toronto team on a full-time basis. Hamid will lead RGI’s growing trials and work with clients to enhance yields using the RotoGro System.

Both of RGI’s state-of-the-art grow rooms have been designed as separate dedicated growing environments for perishable foods and cannabis. During the quarter, RGI completed grow cycles of cherry tomatoes, cabbage, capsicums, lettuce, herbs and chili peppers during the quarter.

Tests focused on different light sources between machines to enable a better understanding of the impact of these on yield, temperature, humidity and nutrient consumption. Results were highly fruitful, confirming the savings in power cost associated with hydroponic growing.

Recent growing trials of perishables at RGI’s Bolton facility:

Next Investors Image

Promisingly, RGI has also determined that there is a valuable revenue stream in offering nutrients in support of its licensed iGrowTM software management system.

On top of that, RGI continues to work with new and existing clients, assisting with design and fit-out solutions for their cannabis growing facilities. These kinds of efforts seen one unlisted client successfully growing three cannabis crops in its test units and progressing to the design of its first phase installation, which will provide for 48 RotoGro Systems.

Managing director, Michael Carli, said: “It has been a very exciting quarter of achievement and progress as our business grows into its three business verticals.”

“The transformation from providing patented and proprietary technology to delivering holistic agricultural solutions from concept to harvest is well under way, with a keen focus on moving to equity and operational positions in growing facilities for both lawful cannabis and perishable foods.”

“Our successful acquisition of an established fertigation business and our investment in urban farming of perishable foods with Gibio are significant steps to creating a solid foundation for our future,” added Carli.

“These achievements, together with the upcoming deliveries for Miracle Valley, new orders and investment opportunities, are a testament to the continual hard work of our team. We are excited about the next quarter as we look to expand our third vertical of agricultural services, and to secure equity participation in a lawful cannabis license,” Carli noted.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.